(64 days)
Not Found
Not Found
No
The summary describes a standard menstrual tampon and does not mention any AI or ML components or functionalities.
No
The device is described as an "unscented menstrual tampon for absorption of menstrual fluid." Its intended use is purely for absorption and does not involve treating, preventing, monitoring, diagnosing, or alleviating a disease or injury, which are characteristics of a therapeutic device.
No
The device is described as an unscented menstrual tampon for absorption of menstrual fluid, and its performance studies focus on safety (e.g., irritation, toxicity) rather than diagnostic capabilities.
No
The device description clearly states it is a physical product (tampons) for absorption of menstrual fluid, not a software application.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "Unscented menstrual tampons for absorption of menstrual fluid." This describes a physical device used for absorption, not a test performed on a sample taken from the body to diagnose or monitor a condition.
- Device Description: The description reinforces the intended use as a physical absorbent device.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any process related to diagnosis or monitoring of a disease or condition.
- Performance Studies: The performance studies listed are related to the safety and physical properties of the tampon (irritation, toxicity, toxin testing), not diagnostic accuracy metrics like sensitivity, specificity, or AUC.
IVDs are devices used to examine specimens derived from the human body to provide information for the diagnosis, prevention, or treatment of a disease or condition. This device does not fit that description.
N/A
Intended Use / Indications for Use
Unscented menstrual tampons for absorption of menstrual fluid.
Product codes (comma separated list FDA assigned to the subject device)
85 HEB
Device Description
The device description is: Unscented menstrual tampons for the absorption of menstrual fluid.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vaginal
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical testing referenced for the determination of substantial equivalence includes: Human sensitization, dermal irritation, acute oral toxicity, subacute vaginal irritations, agar diffusion, Dioxin analysis and TSST-1 toxin testing. Based on the review of the data referenced in this "510(k) Summary," the Playtex Tampons are substantially equivalent to the predicate device in terms of safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 884.5470 Unscented menstrual tampon.
(a)
Identification. An unscented menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. This generic type of device does not include menstrual tampons treated with scent (i.e., fragrance materials) or those with added antimicrobial agents or other drugs.(b)
Classification. Class II (performance standards).
0
JUL 22 1998
9. 510(k) SUMMAR Y
l
P171
SUMMARY OF SAFETY AND EFFECTIVENESS A.
| 1. | COMPANY NAME | - | Playtex Products Inc. |
|---|---|---|---|
| ADDRESS | - | 215 College Road | |
| P. O. Box 728 | |||
| Paramus, New Jersey 07652 | |||
| TELEPHONE | - | 201-265-8000 | |
| CONTACT PERSON | - | M. Rosengarten | |
| Director of Regulatory & Biomedica | |||
| Affairs | |||
| DATE OF SUMMARY | - | May 15, 1998 | |
| 2. | DEVICE NAME | - | Playtex Tampons |
CLASSIFICATION NAME - Unscented Menstrual Tampons
- The new Playtex tampons are substantially equivalent to previously 3. cleared Playtex Gentle Glide® and Silk Glide®Tampons, Regular, Super and Super Plus.
- The device description is: Unscented menstrual tampons for the absorption 4. of menstrual fluid.
- Playtex tampons are intended to be used as unscented menstrual tampons for న. the absorption of menstrual fluid.
-
- The new tampon has the same technological characteristics as the predicate device. The fiber, string and materials in contact with the vaginal wall are the same or have the same mode of action.
- Nonclinical testing referenced for the determination of substantial equivalence B. 1. includes:
Human sensitization, dermal irritation, acute oral toxicity, subacute vaginal irritations, agar diffusion, Dioxin analysis and TSST-1 toxin testing.
-
- Based on the review of the data referenced in this "510(k) Summary," the Playtex Tampons are substantially equivalent to the predicate device in terms of safety and effectiveness.
1
Image /page/1/Picture/2 description: The image shows a logo for the U.S. Department of Health & Human Services. The logo features a stylized representation of three human figures, stacked on top of each other. The figures are black and have a flowing, abstract design. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the figures.
JUL 22 1998
Mr. Mark Rosengarten Director. Regulatory and Biomedical Affairs Research and Development Playtex Products, Inc. 215 College Road, P.O. Box 728 Paramus, NJ 07652
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Re: K981760 Playtex Silk Glide Odor Absorbing Flushable Cardboard Tampons #13598 Dated: May 15, 1998 Received: May 19, 1998 Regulatory Class: II 21 CFR 884.5470/Procode: 85 HEB
Dear Mr. Rosengarten:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the revisions of the Federal Food. Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivaliance compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your deving regulation (21 CFR Part 80) and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/odri/dsmaldsmamain.html".
Sincerely your
Lillian Yin, Ph.D.
Director, Division of Reproducti Abdominal, Ear, Nose and Thro and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
STATEMENT OF INDICATIONS OF USE PAGE
Page _ 1_ of _ 1_
.
جنج
510(k) Number (if known): K 98 l 7 6 o
Device Name: __ Playtex Silk Glide®Tampons
Indications For Use:
Unscented menstrual tampons for absorption of menstrual fluid.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Robert R. Satting/
(Division Sign-Off)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K981760
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use_ }
(Optional Format 1-2-96)